Pancreatic Cancer Trial, Recruiting (NCT06202131)

Pancreatic Cancer Trial, Recruiting NCT06202131 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06202131 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged over 18 years old
People whose general health and ability to perform daily activities is rated at a reasonably functional level (a medical score called ECOG Performance Status below 2 — confirm with trial site)
People who have a confirmed tissue-based diagnosis of a gastrointestinal cancer, specifically cancers of the esophagus, stomach, intestine, pancreas, or bile ducts
People whose scans show disease that is either removable by surgery, locally advanced, or has spread to other parts of the body, at the time of signing the consent form
People whose organs (such as liver and kidneys) are functioning adequately based on blood tests
People for whom a stored or available tissue sample from their tumour exists for testing

Who may not be able to join:

People who do not have a confirmed tissue-based diagnosis of a gastrointestinal cancer
People who are unwilling or unable to provide written informed consent to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisa Sakvatore, MD, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +390630156318

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06202131

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: +390630156318

More information: https://clinicaltrials.gov/study/NCT06202131

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged over 18 years old
People whose general health and ability to perform daily activities is rated at a reasonably functional level (a medical score called ECOG Performance Status below 2 — confirm with trial site)
People who have a confirmed tissue-based diagnosis of a gastrointestinal cancer, specifically cancers of the esophagus, stomach, intestine, pancreas, or bile ducts
People whose scans show disease that is either removable by surgery, locally advanced, or has spread to other parts of the body, at the time of signing the consent form
People whose organs (such as liver and kidneys) are functioning adequately based on blood tests
People for whom a stored or available tissue sample from their tumour exists for testing

Who may not be able to join:

People who do not have a confirmed tissue-based diagnosis of a gastrointestinal cancer
People who are unwilling or unable to provide written informed consent to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registry

ClinicalTrials.gov

Start date

1 November 2023

Est. completion

1 November 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

mOS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov